Drugs that contain Metronidazole
1. Flagyl Er patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6103262 | PFIZER | Modified-release metronidazole compositions and methods for making and using same |
Aug, 2017
(6 years ago) | |
Market Authorisation Date: 26 November, 1997
Treatment: Method of treating bacterial vaginosis
Dosage: TABLET, EXTENDED RELEASE;ORAL
FLAGYL ER family patents
2. Likmez patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11541035 | SAPTALIS PHARMS | Oral formulations of metronidazole and methods of treating an infection using same |
Oct, 2039
(15 years from now) | |
Market Authorisation Date: 22 September, 2023
Treatment: NA
Dosage: SUSPENSION;ORAL
LIKMEZ family patents
3. Metrogel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7348317 | GALDERMA LABS LP | Aqueous compositions containing metronidazole |
Feb, 2022
(2 years ago) | |
| US6881726 | GALDERMA LABS LP | Aqueous compositions containing metronidazole |
Feb, 2022
(2 years ago) | |
Market Authorisation Date: 30 June, 2005
Treatment: Once a day topical treatment of the inflammatory lesions of rosacea
Dosage: GEL;TOPICAL
METROGEL family patents
4. Metrogel-vaginal patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5536743 | BAUSCH | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
Jul, 2013
(10 years ago) | |
Market Authorisation Date: 17 August, 1992
Treatment: Method of treating bacterial vaginosis
Dosage: GEL;VAGINAL
METROGEL-VAGINAL family patents
5. Nuvessa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8877792 | CHEMO RESEARCH SL | Compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
Feb, 2028
(3 years from now) | |
| US7893097 | CHEMO RESEARCH SL | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
Feb, 2028
(3 years from now) | |
| US8658678 | CHEMO RESEARCH SL | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
Jun, 2028
(4 years from now) | |
| US10238634 | CHEMO RESEARCH SL | Aqueous-based metronidazole gel formulations |
Jun, 2032
(8 years from now) | |
| US9198858 | CHEMO RESEARCH SL | Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations |
Jun, 2032
(8 years from now) | |
| US8946276 | CHEMO RESEARCH SL | High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
Jun, 2032
(8 years from now) | |
| US10596155 | CHEMO RESEARCH SL | Aqueous-based metronidazole gel formulations |
Jun, 2032
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Mar 24, 2017 |
Market Authorisation Date: 24 March, 2014
Treatment: Treatment of bacterial vaginosis; Treatment of bacterial vaginosis with metronidazole gel
Dosage: GEL;VAGINAL
NUVESSA family patents
6. Vandazole patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7456207 | TEVA PHARMS | Vaginal pharmaceutical compositions and methods for preparing them |
Sep, 2024
(4 months from now) | |
Market Authorisation Date: 20 May, 2005
Treatment: NA
Dosage: GEL;VAGINAL
VANDAZOLE family patents